
Is PFE (Pfizer Inc.) Halal or Haram?
Pfizer passes all AA OIFI screening criteria with exceptional margins, particularly noting its 0.0% Debt-to-Market Cap ratio which is rare for a major pharmaceutical giant. With interest-bearing income sitting well below the 5% threshold at just 0.9 6%, the company's financial structure is clean and presents minimal shariah concerns for the observant investor.
Shariah Screening Details for PFE
Business Activity
Permissible
Pfizer's core business of developing life-saving medicines like Paxlovid, Eliquis, and various oncology treatments is inherently permissible, as healing and healthcare align with Maqasid al-Shariah.
Debt / Market Cap
0.00%
Interest Income
0.96%
Cash & Securities
0.00%
About Pfizer Inc. (PFE)
Pfizer is a global biopharmaceutical powerhouse known for discovering and manufacturing medicines that treat everything from cardiovascular disease to rare cancers. Beyond its household name status during the pandemic for its COVID-19 vaccine and Paxlovid treatment, its portfolio includes blockbuster drugs like the blood thinner Eliquis and the breast cancer therapy Ibrance. The company operates across a vast range of therapeutic areas, including immunology and internal medicine, making it a cornerstone of the global healthcare infrastructure.
For Muslim investors using Hal alStocks.co.uk, Pfizer represents a clean, shariah-compliant investment opportunity. The stock has successfully passed all four AAOIFI screening tests, confirming that its primary business activities are permissible and its financial ratios are well within halal limits. This ' Halal' designation means you can invest in PFE without the need for complex purification calculations often required for companies with higher interest-based income.
Financially, Pfizer stands out with a remarkably low leverage profile for a company of its size, boasting a Debt-to-Market Cap ratio of 0.0% against the permissible threshold of 33 %. Furthermore, its interest income accounts for only 0.96% of total revenue, which is significantly safer than the 5 % limit allowed by Islamic finance standards. This suggests that the company relies on its actual sales of medicines rather than interest-bearing cash piles to generate value.
While the current snapshot is highly favorable, investors should always keep an eye on Pfizer 's acquisition strategy. Large pharmaceutical companies often acquire smaller biotech firms, which can sometimes alter the parent company's debt profile or introduce new revenue streams that require re-screening. However, as it stands, Pfizer remains a robust, compliant option for a halal portfolio.
CEO
Albert Bourla
Employees
81,000
IPO Date
1972-06-01
Headquarters
New York City, NY, US
Website
www.pfizer.comPFE Key Financial Statistics
Revenue
$62.58B
Net Income
$7.77B
EPS (Diluted)
$1.36
Stock Price
27.06
Beta
0.44
52-Week Range
20.92-27.94
Total Debt
$0
Total Equity
$93.10B
Current Ratio
—
PFE Financial Health & Profitability
Profit Margins
Revenue Growth (YoY)
-1.6%
Prior year: $63.63B
Net Cash
$0
Cash: $0 — Debt: $0
R&D Spending
$11.98B
% of Revenue
19.1%
Frequently Asked Questions About PFE
Is PFE (Pfizer Inc.) stock halal to invest in?▾
What does Pfizer Inc. do?▾
What screening criteria were used for PFE?▾
Does PFE require income purification?▾
When was PFE last screened?▾
Disclaimer
This shariah compliance assessment for PFE (Pfizer Inc.) is provided for informational purposes only and does not constitute financial, investment, or religious advice. Screening criteria are based on widely accepted AAOIFI standards, but individual scholars may differ in their opinions. Always consult with a qualified Islamic scholar and licensed financial advisor before making investment decisions. Past screening status does not guarantee future compliance. Last screened: 2026-02-24.